Novartis has received EU approval for its new flu vaccine, Optaflu. The approval puts the pharma giant on track for the first launch of a cell-based flu vaccine. Release
Novartis has received EU approval for its new flu vaccine, Optaflu. The approval puts the pharma giant on track for the first launch of a cell-based flu vaccine. Release